Nppa
-
{
- All
- News
- Videos
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
China Cuts Down Playing Time for Under-18 Gamers to 3 Hours a Week
China has stepped up its social policing and introduced new restrictions for under-18 gamers. The rules now say they can’t play for more than three hours a week — an hour each day over the weekend.
-
Pricing Formula For Oxygen Concentrators Being Fixed, Centre Tells Court
The Centre Tuesday informed the Delhi High Court that pricing authority NPPA has initiated the process to fix a formula to determine the MRP of oxygen concentrators, needed for COVID-19 treatment, as people were being charged exorbitantly.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Prices Of N-95 Masks Fall 47% After Pharma Pricing Body's Advisory: Government
Leading manufacturers and importers of N-95 masks have reduced prices by up to 47 per after regulator NPPA stepped in to ensure the availability of this respiratory protection device at affordable rates in the country, the government said on Monday.
-
In "Larger Public Interest", Stent Prices Further Cut By Over 6%
Shashank Kapoor, 32, is overjoyed. Last month, his father suffered a cardiac arrest and needed two stents. The five-day stay at a private hospital set the counsellor back by over Rs 1 lakh, one-third of which was just the price of the two stents.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Cancer, Diabetes and HIV Drugs To Become Cheaper Post GST
Country's drug price regulator, NPPA has stepped in and released a notification on keeping the cost of key medicines affordable by revising prices of 761 drugs.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
China Cuts Down Playing Time for Under-18 Gamers to 3 Hours a Week
China has stepped up its social policing and introduced new restrictions for under-18 gamers. The rules now say they can’t play for more than three hours a week — an hour each day over the weekend.
-
Pricing Formula For Oxygen Concentrators Being Fixed, Centre Tells Court
The Centre Tuesday informed the Delhi High Court that pricing authority NPPA has initiated the process to fix a formula to determine the MRP of oxygen concentrators, needed for COVID-19 treatment, as people were being charged exorbitantly.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Prices Of N-95 Masks Fall 47% After Pharma Pricing Body's Advisory: Government
Leading manufacturers and importers of N-95 masks have reduced prices by up to 47 per after regulator NPPA stepped in to ensure the availability of this respiratory protection device at affordable rates in the country, the government said on Monday.
-
In "Larger Public Interest", Stent Prices Further Cut By Over 6%
Shashank Kapoor, 32, is overjoyed. Last month, his father suffered a cardiac arrest and needed two stents. The five-day stay at a private hospital set the counsellor back by over Rs 1 lakh, one-third of which was just the price of the two stents.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Cancer, Diabetes and HIV Drugs To Become Cheaper Post GST
Country's drug price regulator, NPPA has stepped in and released a notification on keeping the cost of key medicines affordable by revising prices of 761 drugs.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
